Of these, Interleukin-6 (IL-6) and Stromal-Derived Factor-1 (SDF-1) are arguably the most significant in MM and AML pathogenesis and have been shown to be stimulated by tumour cell/BMM cell interactions. The gene discussed is IL6; the disease is Miyoshi myopathy.